How severe is CVE-2023-53734?

CVE-2023-53734 has a CVSS 4.0 base score of 8.7, rated high severity.

Is CVE-2023-53734 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (37th percentile), an estimate of the probability of exploitation in the next 30 days.

How do I fix CVE-2023-53734?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

Does CVE-2023-53734 have an EU (EUVD) identifier?

Yes. CVE-2023-53734 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-201278.

When was CVE-2023-53734 published?

CVE-2023-53734 was published on 2025-12-04 and last updated on 2026-06-17.

CVE-2023-53734

CVE-2023-53734 is a high-severity vulnerability with a CVSS 4.0 base score of 8.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.

Key facts

Severity: High (CVSS 4.0 base score 8.7)
EPSS exploit prediction: 0% (37th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-201278
Weakness: CWE-89
Published: 2025-12-04
Last modified: 2026-06-17

Description

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Frequently asked questions

What is CVE-2023-53734?: dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
How severe is CVE-2023-53734?: CVE-2023-53734 has a CVSS 4.0 base score of 8.7, rated high severity.
Is CVE-2023-53734 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (37th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2023-53734?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2023-53734 have an EU (EUVD) identifier?: Yes. CVE-2023-53734 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-201278.
When was CVE-2023-53734 published?: CVE-2023-53734 was published on 2025-12-04 and last updated on 2026-06-17.

References

Other CWE-89 (SQL Injection) vulnerabilities

CVE-2026-54350 — Critical (CVSS 10.0): Budibase is an open-source low-code platform. Prior to 3.39.12, an unauthenticated visitor of any published Budibase…
CVE-2026-8054 — Critical (CVSS 10.0): Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') in the Publish Audit API endpoints…
CVE-2026-42287 — Critical (CVSS 10.0): Emlog is an open source website building system. Prior to version 2.6.11, direct SQL injection in article creation and…
CVE-2026-3325 — Critical (CVSS 10.0): SQL injection (SQLi) in MegaCMS v12.0.0, specifically in the “id_territorio” parameter of the…
CVE-2025-10878 — Critical (CVSS 10.0): A SQL injection vulnerability exists in the login functionality of Fikir Odalari AdminPando 1.0.1 before 2026-01-26.…
CVE-2025-57792 — Critical (CVSS 10.0): Explorance Blue versions prior to 8.14.9 contain a SQL injection vulnerability caused by insufficient validation of…

Browse all CWE-89 (SQL Injection) vulnerabilities →